SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001047469-14-004658
Filing Date
2014-05-07
Accepted
2014-05-06 21:22:40
Documents
12

Document Format Files

Seq Description Document Type Size
1 10-12B/A a2220057z10-12ba.htm 10-12B/A 68371
2 EX-10.8 a2220057zex-10_8.htm EX-10.8 25679
3 EX-10.16 a2220057zex-10_16.htm EX-10.16 405985
4 EX-10.17 a2220057zex-10_17.htm EX-10.17 447069
5 EX-10.18 a2220057zex-10_18.htm EX-10.18 392155
6 EX-10.31 a2220057zex-10_31.htm EX-10.31 82352
7 EX-10.32 a2220057zex-10_32.htm EX-10.32 20637
8 EX-21.1 a2220057zex-21_1.htm EX-21.1 1928
9 EX-99.1 a2220057zex-99_1.htm EX-99.1 1388388
10 G758262.JPG g758262.jpg GRAPHIC 6845
11 G553691.JPG g553691.jpg GRAPHIC 108996
12 G175232LC11I001.JPG g175232lc11i001.jpg GRAPHIC 22916
  Complete submission text file 0001047469-14-004658.txt   3025207
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-36033 | Film No.: 14818677
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences